Gemtuzumab and neutropenia 
Gemtuzumab and neutropenia Patient Reports February 13, 2012
Gemtuzumab Side Effects Report #6119964-3
Gemtuzumab side effect was reported by a Physician from JAPAN on Mar 10, 2009. Male patient, 75 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia
, thrombocytopenia. Gemtuzumab dosage: 9 MG/M^2 ON DAY 1 AND 15. Patient died.Gemtuzumab Side Effects Report #6119965-5
Gemtuzumab side effect was reported by a Physician from JAPAN on Mar 10, 2009. Female patient, 61 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia, pneumonia
, thrombocytopenia. Gemtuzumab dosage: 9 MG/M^2 ON DAY 1 AND 15. Patient died.Gemtuzumab Side Effects Report #4680268-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from on May 19, 2005. Male patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balanoposthitis, haemoglobin decreased, neutropenia, platelet count decreased, pseudomonas infection, staphylococcal sepsis. Gemtuzumab dosage: 10.2 MG 1X PER 1 DAY. During the same period patient was treated with FEXOFENADINE, ESOMEPRAZOLE, MAGALDRATE, DEXAMETHASONE, CHLORPHENAMINE, ONDANSETRON, ELECTROLYTE SOLUTIONS, BICARBONATE IN PLASTIC CONTAINER. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4746699-1
Gemtuzumab side effect was reported by a Health Professional from ITALY on Aug 04, 2005. Male patient, 41 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balanoposthitis, culture urine positive, neutropenia, platelet count decreased, pseudomonas infection, staphylococcal sepsis. Gemtuzumab dosage: 10.2 MG 1X PER 1 DAY; SECOND DOSE. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, FEXOFENAIDNE, ESOMEPRAZOLE, MAGALDRATE, DEXAMETHASONE, CHLORPHENAMINE, ONDANSETRON, ELECTROLYTE SOLUTOINS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4620958-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Mar 17, 2005. Male patient, 33 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia. Gemtuzumab dosage: 6 MG/M2 TWICE A MONTH INTRAVENOUS. During the same period patient was treated with LEVOFLOXACIN, AMPHOTERICIN B. Patient recovered.
Gemtuzumab Side Effects Report #4620960-3
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Mar 17, 2005. Male patient, 33 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia. Gemtuzumab dosage: 6MG/M2 TWICE A MONTH INTRAVENOUS. During the same period patient was treated with LEVOFLOXACIN, AMPHOTERICIN B. Patient recovered.
Gemtuzumab Side Effects Report #4639084-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Apr 06, 2005. Female patient, 29 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, stomatitis. Gemtuzumab dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4686095-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from on May 27, 2005. Female patient, 29 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, sepsis
, staphylococcal infection , stomatitis. Gemtuzumab dosage: 6 MG 1X PER 1 DAY INTRAVENOUS. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5134221-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Oct 10, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplasia, neutropenia, oliguria, pneumonitis, septic shock, syncope, thrombocytopenia. Gemtuzumab dosage: 9.5 MG. During the same period patient was treated with FUROSEMIDE, MEROPENEM, AMIKACIN, TEICOPLANIN. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5192195-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Dec 18, 2006. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, neutropenia, pneumonitis, septic shock, thrombocytopenia. Gemtuzumab dosage: 9.5 MG,. During the same period patient was treated with FUROSEMIDE, MEROPENEM, AMIKACIN, TEICOPLANIN. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867043-5
Gemtuzumab side effect was reported by a Health Professional from CANADA on Oct 06, 1998. Female patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blast cell count increased, cerebral infarction, convulsion, dry mouth, grand mal convulsion, neutropenia, thrombocytopenia. Gemtuzumab dosage: 9 MG/SQ.M INTRAVENOUS 1 DOS. Patient was hospitalized. Patient died.
Gemtuzumab Side Effects Report #4867092-7
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Apr 13, 2002. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: leukopenia, neutropenia. Gemtuzumab dosage: unknown. Patient died on 04/12/1999.
Gemtuzumab Side Effects Report #5023796-7
Gemtuzumab side effect was reported by a Physician from ITALY on May 23, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balance disorder, chills, dysphagia, faecal incontinence, gait disturbance, hyporeflexia, neutropenia, peripheral sensorimotor neuropathy, pyrexia. Gemtuzumab dosage: 3 MG/M^2 1X PER 1 DAY INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867726-7
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Apr 13, 2002. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, back pain
, bacterial sepsis, disease progression, granulocytopenia, hyponatraemia, neutropenia, oedema peripheral. Gemtuzumab dosage: unknown. Patient died on 07/27/1998.Gemtuzumab Side Effects Report #4867734-6
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Dec 22, 2005. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: lymphadenitis, neutropenia, pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4928868-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Feb 15, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: abdominal pain
, anuria, atelectasis, hypotension, intestinal ischaemia, neutropenia, pleural effusion, septic shock. Gemtuzumab dosage: 9 MG 1X PER 1 DAY. During the same period patient was treated with MEROPENEM, AMIKACIN, TEICOPLANIN. Patient died.Gemtuzumab Side Effects Report #4911220-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from SPAIN on June 28, 2001. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood potassium decreased, catheter related infection, haemoglobin decreased, neutropenia, platelet count decreased, post procedural complication, staphylococcal infection
. Gemtuzumab dosage: 6 MG/M^2 1X PER 1 DOS INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #4721920-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 07, 2005. Female patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, blood pressure decreased, malaise, neutropenia, staphylococcal bacteraemia. Gemtuzumab dosage: unknown. Patient died.Gemtuzumab Side Effects Report #4737037-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 08, 2005. Female patient, 59 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial fibrillation
, blood pressure decreased, neutropenia, staphylococcal bacteraemia. Gemtuzumab dosage: unknown. Patient died.Gemtuzumab Side Effects Report #4867129-5
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Mar 10, 2002. Female patient, 46 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, haemorrhage, menometrorrhagia, neutropenia, thrombocytopenia. Gemtuzumab dosage: 9 MG/M (2) INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died.
Gemtuzumab Side Effects Report #4914117-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 09, 2002. Female patient, 33 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, platelet count decreased, pyrexia, tooth abscess. Gemtuzumab dosage: 9 MG/^2 1X PER 1 DOS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867028-9
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Oct 28, 1999. Male patient, 26 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: eosinophil percentage increased, leukopenia, lymphocyte percentage increased, nausea
, neutropenia, platelet count decreased, pyrexia. Gemtuzumab dosage: 9 MG/M (2) (TOTAL DOSE: 16 MG/DOSE) INTRAVENOUS 2 DOS. During the same period patient was treated with SPORANOX, ANZEMET, PLITICAN, POLARAMINE. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5294845-6
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 10, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, capillary leak syndrome, cardiac failure, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TARGOCID, TOBRACIN, DIFLUCAN. Patient died on 03/22/2006.
Gemtuzumab Side Effects Report #5297246-X
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 10, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aspergillosis, neutropenia, pneumonia
, sepsis , thrombocytopenia. Gemtuzumab dosage: DAILY DOSE 5 MG;CUMULATIVE DOSE 15 MG. Patient was hospitalized. Patient died on 11/08/2006.Gemtuzumab Side Effects Report #5519868-0
Gemtuzumab side effect was reported by a Physician from BELGIUM on Nov 14, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, capillary leak syndrome, cardiac failure, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TARGOCID, TOBRACIN, DIFLUCAN. Patient died on 03/22/2006.
Gemtuzumab Side Effects Report #5520558-9
Gemtuzumab side effect was reported by a Physician from BELGIUM on Nov 14, 2007. Female patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aspergillosis, neutropenia, pneumonia
, sepsis , thrombocytopenia. Gemtuzumab dosage: DAILY DOSE 5 MG;CUMULATIVE DOSE 15 MG. Patient was hospitalized. Patient died on 11/08/2006.Gemtuzumab Side Effects Report #5928542-8
Gemtuzumab side effect was reported by a Physician from BELGIUM on Oct 21, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, capillary leak syndrome, cardiac failure, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TARGOCID, TOBRACIN, DIFLUCAN. Patient died on 03/22/2006.
Gemtuzumab Side Effects Report #5623064-6
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 08, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: fungal infection
, neutropenia, pneumonia . Gemtuzumab dosage: 3 MG/M^2 EVERY 1 TOT. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 07/05/2007.Gemtuzumab Side Effects Report #5625866-9
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 08, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: fungal infection
, neutropenia, pneumonia . Gemtuzumab dosage: 3 MG/M^2 EVERY 1 TOT. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 07/05/2007.Gemtuzumab Side Effects Report #5643472-7
Gemtuzumab side effect was reported by a Physician from UNITED KINGDOM on Feb 25, 2008. Male patient was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: fungal infection
, neutropenia, pneumonia . Gemtuzumab dosage: 3 MG/M^2 EVERY 1 TOT. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 07/05/2007.